ASB15
gene geneOn this page
Also known as FLJ43370
Summary
ASB15 (ankyrin repeat and SOCS box containing 15, HGNC:19767) is a protein-coding gene on chromosome 7q31.32, encoding Ankyrin repeat and SOCS box protein 15 (Q8WXK1). May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
This gene encodes a member of the suppressor of cytokine signaling box superfamily. The proteins in this superfamily participate in the ubiquitin-proteasome system for the degradation of proteins in the cell cycle and signal transduction pathways. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 142685 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 91 total
- MANE Select transcript:
NM_001290258
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:19767 |
| Approved symbol | ASB15 |
| Name | ankyrin repeat and SOCS box containing 15 |
| Location | 7q31.32 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ43370 |
| Ensembl gene | ENSG00000146809 |
| Ensembl biotype | protein_coding |
| OMIM | 619757 |
| Entrez | 142685 |
Gene structure
Transcript identifiers
Ensembl transcripts: 53 — 53 protein_coding
ENST00000275699, ENST00000434204, ENST00000437535, ENST00000447789, ENST00000451215, ENST00000451558, ENST00000883309, ENST00000883310, ENST00000883311, ENST00000883312, ENST00000883313, ENST00000883314, ENST00000883315, ENST00000883316, ENST00000883317, ENST00000883318, ENST00000883319, ENST00000883320, ENST00000883321, ENST00000883322, ENST00000883323, ENST00000883324, ENST00000883325, ENST00000883326, ENST00000883327, ENST00000883328, ENST00000944011, ENST00000944012, ENST00000944013, ENST00000944014, ENST00000944015, ENST00000944016, ENST00000944017, ENST00000944018, ENST00000944019, ENST00000944020, ENST00000944021, ENST00000944022, ENST00000944023, ENST00000944024, ENST00000944025, ENST00000944026, ENST00000944027, ENST00000944028, ENST00000944029, ENST00000944030, ENST00000944031, ENST00000944032, ENST00000944033, ENST00000944034, ENST00000944035, ENST00000944036, ENST00000944037
RefSeq mRNA: 2 — MANE Select: NM_001290258
NM_001290258, NM_080928
CCDS: CCDS34742
Canonical transcript exons
ENST00000451215 — 12 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000977399 | 123627110 | 123627281 |
| ENSE00001086542 | 123628864 | 123629434 |
| ENSE00001136383 | 123629966 | 123630119 |
| ENSE00001384078 | 123624569 | 123624814 |
| ENSE00001592803 | 123608594 | 123608654 |
| ENSE00001621957 | 123636809 | 123639481 |
| ENSE00001743353 | 123604032 | 123604212 |
| ENSE00001748037 | 123601821 | 123601914 |
| ENSE00003712008 | 123614501 | 123614609 |
| ENSE00003719759 | 123616221 | 123616273 |
| ENSE00003743403 | 123617579 | 123617737 |
| ENSE00003787794 | 123616364 | 123616495 |
Expression profiles
Bgee: expression breadth broad, 68 present calls, max score 91.21.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.2240 / max 43.4780, expressed in 34 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 80851 | 0.0991 | 27 |
| 80852 | 0.0662 | 26 |
| 204676 | 0.0587 | 24 |
Top tissues by expression
216 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| hindlimb stylopod muscle | UBERON:0004252 | 91.21 | gold quality |
| apex of heart | UBERON:0002098 | 88.54 | gold quality |
| muscle of leg | UBERON:0001383 | 85.74 | gold quality |
| gastrocnemius | UBERON:0001388 | 85.74 | gold quality |
| heart left ventricle | UBERON:0002084 | 84.57 | gold quality |
| cardiac ventricle | UBERON:0002082 | 83.76 | gold quality |
| skeletal muscle tissue of rectus abdominis | UBERON:0004511 | 83.64 | gold quality |
| right atrium auricular region | UBERON:0006631 | 82.13 | gold quality |
| cardiac atrium | UBERON:0002081 | 81.42 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 81.35 | gold quality |
| vastus lateralis | UBERON:0001379 | 81.01 | gold quality |
| quadriceps femoris | UBERON:0001377 | 80.75 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 79.84 | gold quality |
| heart | UBERON:0000948 | 77.11 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 76.02 | silver quality |
| muscle tissue | UBERON:0002385 | 75.07 | gold quality |
| biceps brachii | UBERON:0001507 | 74.53 | silver quality |
| deltoid | UBERON:0001476 | 70.33 | gold quality |
| sperm | CL:0000019 | 65.16 | silver quality |
| buccal mucosa cell | CL:0002336 | 62.46 | gold quality |
| heart right ventricle | UBERON:0002080 | 62.22 | silver quality |
| endothelial cell | CL:0000115 | 60.98 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 58.06 | gold quality |
| myocardium | UBERON:0002349 | 57.83 | gold quality |
| body of tongue | UBERON:0011876 | 57.15 | silver quality |
| gingival epithelium | UBERON:0001949 | 57.08 | gold quality |
| seminal vesicle | UBERON:0000998 | 56.18 | gold quality |
| amniotic fluid | UBERON:0000173 | 55.42 | gold quality |
| gingiva | UBERON:0001828 | 55.36 | gold quality |
| tongue | UBERON:0001723 | 55.26 | silver quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-75367 | no | 14.09 |
| E-ANND-3 | no | 4.00 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
68 targeting ASB15, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-432-3P | 100.00 | 67.86 | 705 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-6077 | 99.99 | 68.04 | 2299 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-6793-5P | 99.97 | 65.95 | 758 |
| HSA-MIR-551B-5P | 99.96 | 71.28 | 3493 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-1305 | 99.91 | 71.43 | 3443 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-4420 | 99.82 | 70.08 | 1624 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-4495 | 99.82 | 72.08 | 3080 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-181B-2-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-181B-3P | 99.81 | 70.06 | 1646 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-498-5P | 99.76 | 69.64 | 1807 |
| HSA-MIR-3617-5P | 99.75 | 69.41 | 1968 |
| HSA-MIR-641 | 99.75 | 69.35 | 1975 |
| HSA-MIR-3618 | 99.69 | 68.57 | 1012 |
| HSA-MIR-4663 | 99.62 | 65.33 | 957 |
| HSA-MIR-4762-5P | 99.57 | 68.54 | 1424 |
| HSA-MIR-4672 | 99.50 | 71.58 | 2893 |
| HSA-MIR-4441 | 99.49 | 66.56 | 3216 |
| HSA-MIR-4311 | 99.31 | 70.47 | 3041 |
Literature-anchored findings (GeneRIF, showing 3)
- ASB15 gene, consisting of 12 exons, was identified by using bio-informatics. (PMID:16012773)
- The apparent occurrence of an unusual TG 3’ splice site in intron 9 is critically discussed. (PMID:17672918)
- Genome-wide association study reveals two novel risk alleles for incident obstructive sleep apnea in the EPISONO cohort. (PMID:31786426)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | asb15a | ENSDARG00000045633 |
| danio_rerio | asb15b | ENSDARG00000045863 |
| mus_musculus | Asb15 | ENSMUSG00000029685 |
| rattus_norvegicus | Asb15 | ENSRNOG00000006365 |
Paralogs (7): ASB4 (ENSG00000005981), ASB3 (ENSG00000115239), ASB10 (ENSG00000146926), ASB16 (ENSG00000161664), ASB18 (ENSG00000182177), MPHOSPH8 (ENSG00000196199), ASB14 (ENSG00000239388)
Protein
Protein identifiers
Ankyrin repeat and SOCS box protein 15 — Q8WXK1 (reviewed: Q8WXK1)
All UniProt accessions (4): Q8WXK1, A0A0C4DG46, A0A384NYV2, C9J956
UniProt curated annotations — full annotation on UniProt →
Function. May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins.
Domain organisation. The SOCS box domain mediates the interaction with the Elongin BC complex, an adapter module in different E3 ubiquitin-protein ligase complexes.
Pathway. Protein modification; protein ubiquitination.
Similarity. Belongs to the ankyrin SOCS box (ASB) family.
RefSeq proteins (2): NP_001277187, NP_563616 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001496 | SOCS_box | Domain |
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR036036 | SOCS_box-like_dom_sf | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
Pfam: PF07525, PF12796, PF13606
UniProt features (14 total): repeat 9, sequence variant 2, chain 1, domain 1, sequence conflict 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8WXK1-F1 | 87.39 | 0.70 |
Function
Pathways and Gene Ontology
Reactome pathways
7 pathways
| ID | Pathway |
|---|---|
| R-HSA-8951664 | Neddylation |
| R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation |
| R-HSA-1280218 | Adaptive Immune System |
| R-HSA-168256 | Immune System |
| R-HSA-392499 | Metabolism of proteins |
| R-HSA-597592 | Post-translational protein modification |
| R-HSA-983169 | Class I MHC mediated antigen processing & presentation |
MSigDB gene sets: 74 (showing top):
GSE45365_CTRL_VS_MCMV_INFECTION_NK_CELL_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION, GCANCTGNY_MYOD_Q6, CAGCAGG_MIR370, GOBP_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MYOD_Q6, CUI_TCF21_TARGETS_2_DN, CAGCCTC_MIR4855P, chr7q31, REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION, MIKKELSEN_ES_ICP_WITH_H3K4ME3, MIKKELSEN_NPC_ICP_WITH_H3K4ME3, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D
GO Biological Process (2): protein ubiquitination (GO:0016567), intracellular signal transduction (GO:0035556)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): cytosol (GO:0005829)
Reactome top-level categories
Rollup of top-5 pathways:
| Category | Pathways |
|---|---|
| Post-translational protein modification | 1 |
| Class I MHC mediated antigen processing & presentation | 1 |
| Immune System | 1 |
| Metabolism of proteins | 1 |
| Adaptive Immune System | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| protein modification by small protein conjugation | 1 |
| intracellular anatomical structure | 1 |
| signal transduction | 1 |
| binding | 1 |
| cytoplasm | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1218 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ASB15 | LMOD2 | Q6P5Q4 | 497 |
| ASB15 | IQUB | Q8NA54 | 492 |
| ASB15 | SLC13A1 | Q9BZW2 | 491 |
| ASB15 | WDR49 | Q8IV35 | 475 |
| ASB15 | KAAG1 | Q9UBP8 | 474 |
| ASB15 | PLEKHH3 | Q7Z736 | 454 |
| ASB15 | NDUFA5 | Q16718 | 433 |
| ASB15 | ASB6 | Q9NWX5 | 431 |
| ASB15 | CISH | Q9NSE2 | 421 |
| ASB15 | KLHL13 | Q9P2N7 | 419 |
| ASB15 | CBY3 | A6NI87 | 413 |
| ASB15 | GRIFIN | A4D1Z8 | 409 |
| ASB15 | SAXO1 | Q8IYX7 | 387 |
| ASB15 | ASB4 | Q9Y574 | 386 |
| ASB15 | IFT70A | Q86WT1 | 380 |
IntAct
41 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| KANK2 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LMO1 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRPF31 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| CCDC13 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASB15 | ZNF587 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PRR35 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MGC50722 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFYVE26 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GEM | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ASB15 | GPSM3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| USHBP1 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| KRT75 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HDAC4 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.560 |
| P | psi-mi:“MI:0914”(association) | 0.350 | |
| KANK2 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| HDAC4 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZFYVE26 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GEM | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| GPSM3 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| USHBP1 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| LMO1 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRPF31 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| CCDC13 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| ZNF587 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| PRR35 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
| MGC50722 | ASB15 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (33): ASB15 (Two-hybrid), ASB15 (Two-hybrid), ASB15 (Two-hybrid), ASB15 (Two-hybrid), PRR35 (Two-hybrid), GEM (Two-hybrid), LMO1 (Two-hybrid), KRT75 (Two-hybrid), KANK2 (Two-hybrid), ZNF587 (Two-hybrid), GPSM3 (Two-hybrid), CCDC13 (Two-hybrid), MGC50722 (Two-hybrid), ASB15 (Affinity Capture-MS), CUL5 (Affinity Capture-MS)
ESM2 similar proteins: A0JM56, A0JPI9, A2BFL2, A5PK13, A6H639, J9SQF3, O13066, P19686, P33402, Q02108, Q0VAA2, Q14BP6, Q15111, Q15813, Q3USB7, Q498T9, Q4R642, Q4V8D9, Q4ZHS0, Q5DU41, Q5FVQ9, Q5RAG3, Q5RBD9, Q5RJH2, Q5ZIJ9, Q5ZIU8, Q62688, Q68F79, Q6DN12, Q6GQN5, Q6NU09, Q6P9F7, Q6WRX3, Q7Z7L7, Q80ZJ6, Q8BG40, Q8CDU4, Q8CIR4, Q8CIV8, Q8HXA6
Diamond homologs: A2RUV0, A6NK59, O35516, P0C927, Q04721, Q3SX45, Q58CT0, Q5U2S6, Q8C6Y6, Q8HXA6, Q8K0L0, Q8VHS6, Q8WXK1, Q96Q27, Q9QW30, A2ARS0, C9JTQ0, Q3KP44, Q9W0T5, A6QR20, P20749, Q08DV6, Q4FE45, Q6KAE5, Q6NLQ8, Q7M6U3, Q9BQI6, Q9WV72, Q9Y575, Q9Z2F6, A2RT91, Q3V096, Q7Z5J8, Q8N9B4, Q9WV74, Q9Y576, Q9P2R3, Q9J519, A0A0R4IQZ2, A2AQH4
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
91 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 84 |
| Likely benign | 4 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1762 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 7:123616491:GGATG:G | donor_gain | 1.0000 |
| 7:123616492:GATGG:G | donor_gain | 1.0000 |
| 7:123624556:A:AG | acceptor_gain | 1.0000 |
| 7:123624557:A:G | acceptor_gain | 1.0000 |
| 7:123624566:A:AG | acceptor_gain | 1.0000 |
| 7:123624566:AAGCT:A | acceptor_gain | 1.0000 |
| 7:123624567:A:G | acceptor_gain | 1.0000 |
| 7:123624568:GCT:G | acceptor_gain | 1.0000 |
| 7:123624813:AGGTA:A | donor_loss | 1.0000 |
| 7:123624815:G:GG | donor_gain | 1.0000 |
| 7:123624816:T:A | donor_loss | 1.0000 |
| 7:123627105:GCCA:G | acceptor_loss | 1.0000 |
| 7:123627106:CCAGG:C | acceptor_loss | 1.0000 |
| 7:123627279:TCT:T | donor_gain | 1.0000 |
| 7:123627280:CTG:C | donor_loss | 1.0000 |
| 7:123627281:TGT:T | donor_loss | 1.0000 |
| 7:123627282:G:GG | donor_gain | 1.0000 |
| 7:123627282:GTGA:G | donor_loss | 1.0000 |
| 7:123627283:T:G | donor_loss | 1.0000 |
| 7:123627284:G:GC | donor_loss | 1.0000 |
| 7:123627286:G:C | donor_loss | 1.0000 |
| 7:123628862:A:AG | acceptor_gain | 1.0000 |
| 7:123628863:G:GG | acceptor_gain | 1.0000 |
| 7:123629230:T:G | acceptor_gain | 1.0000 |
| 7:123614489:A:AG | acceptor_gain | 0.9900 |
| 7:123614490:A:G | acceptor_gain | 0.9900 |
| 7:123614494:T:G | acceptor_gain | 0.9900 |
| 7:123614495:A:AG | acceptor_gain | 0.9900 |
| 7:123614495:AT:A | acceptor_gain | 0.9900 |
| 7:123614496:T:G | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000037413 (7:123583351 G>A), RS1000061682 (7:123599846 G>T), RS1000093336 (7:123617173 T>G), RS1000115003 (7:123599507 TC>T), RS1000176521 (7:123625655 A>G), RS1000181955 (7:123600418 G>C), RS1000209286 (7:123618696 T>C), RS1000295772 (7:123605974 A>C), RS1000376802 (7:123623312 A>G), RS1000529942 (7:123575363 T>A,C,G), RS1000532378 (7:123605407 A>C,G), RS1000638025 (7:123599282 A>G), RS1000641385 (7:123594858 G>C,T), RS1000706543 (7:123600732 G>A), RS1000717121 (7:123568524 G>A,T)
Disease associations
OMIM: gene MIM:619757 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004719_2 | Left ventricular obstructive tract defect (inherited effect) | 2.000000e-06 |
| GCST006231_33 | Mean arterial pressure | 7.000000e-06 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0006340 | mean arterial pressure |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| titanium dioxide | increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Plant Extracts | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): congenital left-sided heart lesions